Paper Details

  1. Home
  2. Paper Details

Neuroprotective effects of protocatechuic aldehyde against neurotoxin-induced cellular and animal models of Parkinson's disease.

Author: AnMing-Sheng, GeHui-Qi, LiuJin-Hao, PuXiao-Ping, WangYue-Hua, YangYing-Fan, ZhaiShenyu, ZhaoXin

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study investigates the neuroprotective effects of protocatechuic aldehyde (PAL) against neurotoxin-induced cell and animal models of Parkinson's disease (PD).
Paper Details　
Original Abstract of the Article :
Protocatechuic aldehyde (PAL) has been reported to bind to DJ-1, a key protein involved in Parkinson's disease (PD), and exerts potential neuroprotective effects via DJ-1 in SH-SY5Y cells. In this study, we investigated the neuroprotective pharmacological effects of PAL against neurotoxin-induced ce...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3799719/

データ提供：米国国立医学図書館（NLM）

Protocatechuic Aldehyde: A Potential Neuroprotective Agent for Parkinson's Disease

Parkinson's disease, a neurodegenerative disorder that affects movement, is a complex and debilitating condition. This study investigates the neuroprotective effects of protocatechuic aldehyde (PAL) against neurotoxin-induced cell and animal models of Parkinson's disease. The researchers found that PAL protects dopaminergic neurons from damage in both cell and animal models, suggesting its potential as a therapeutic agent for Parkinson's disease.

Protocatechuic Aldehyde: A Potential Therapeutic Agent for Parkinson's Disease

This study provides promising evidence for the neuroprotective potential of protocatechuic aldehyde (PAL) in Parkinson's disease. The study's findings, based on both cell and animal models, suggest that PAL protects dopaminergic neurons from damage, highlighting its potential as a therapeutic agent for this neurodegenerative disorder. Further research is needed to confirm these findings and to explore the potential of PAL in humans, but this study provides a valuable starting point for developing new and effective treatments for Parkinson's disease.

Protocatechuic Aldehyde: A Glimpse of Hope for Parkinson's Disease

This study offers a glimmer of hope for individuals with Parkinson's disease. The researchers found that protocatechuic aldehyde (PAL) protects dopaminergic neurons from damage in both cell and animal models, suggesting its potential as a therapeutic agent for this neurodegenerative disorder. While further investigation is necessary, this study provides a valuable starting point for exploring the efficacy and safety of PAL in this specific patient population.

Dr.Camel's Conclusion

This study provides promising evidence for the neuroprotective potential of protocatechuic aldehyde (PAL) in Parkinson's disease. The findings suggest that PAL could offer a new avenue for treatment and a potential oasis of hope for individuals struggling with this debilitating condition. This research highlights the importance of exploring natural and plant-derived compounds for their potential therapeutic applications in neurodegenerative disorders.
Date :
  1. Date Completed 2015-02-23
  2. Date Revised 2023-11-10
Further Info :

Pubmed ID

24205164

DOI: Digital Object Identifier

PMC3799719

Related Literature

Article Analysis
・Effects of apomorphine injection
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.